Skip to content

Influencing Factors on Gait Variability in PD

Influencing Factors and Improving Strategy on Gait Variability in People With Parkinson's Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05109897
Enrollment
100
Registered
2021-11-05
Start date
2021-11-01
Completion date
2022-12-31
Last updated
2021-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson's disease, Gait variability

Brief summary

The principal motor features of Parkinson's disease (PD) include rigidity, tremor, bradykinesia, and postural instability. These motor deficits might cause gait dysfunction including reduced gait velocity, stride length, arm swing, and increased gait variability. Among these, increase in gait variability increased fall risk and served as a marker of disease progression. Previous studies reported that some factors might influence gait variability. However, which one contributes most has not yet been verified. Therefore, the purpose of the present study is to identify the more related influencing factors on gait variability in people with PD.

Interventions

None listed

Sponsors

National Yang Ming Chiao Tung University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Idiopathic PD * Hoehn and Yahr stages I through III * Ability to stand and walk 5 m independently with or without any walking aids * Stable medication usage

Exclusion criteria

* Unstable medical conditions * Any neurological, cardiopulmonary or orthopedic problem/diseases that may interfere with participating the study

Design outcomes

Primary

MeasureTime frameDescription
Gait variability10 minutesUsing GAITRite system to measure coefficient of variation
Walking speed10 minutesUsing GAITRite system to evaluate
Sensory organization test20 minutesUsing NeuroCom Smart Balance Master to measure
Part III of the Unified Parkinson's Disease Rating Scale20 minutesThe score ranged from 0 to 72. Higher scores show increased severity.
Tinetti Balance Scale10 minutesThe score ranged from 0 to 28. Higher scores show better balance.
New freezing of gait questionnaire15 minutesThe score ranged from 0 to 29. Higher scores show increased severity in freezing of gait.
Montreal Cognitive Assessment20 minutesThe score ranged from 0 to 30. Higher scores show better cognitive function.

Countries

Taiwan

Contacts

Primary ContactYea-Ru Yang, PhD
yryang@nycu.edu.tw886228267279

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026